Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License and Appoints New Member to Executive Team
Submitted application to Health Canada for license that will allow in-house research in new facility Appointed Dr. Ed Ergenzinger to executive team as chief legal officer and senior VP of innovation Recruiting new staff, expanding work schedules and reducing costs and development timelines Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a biotech company and drug delivery platform innovator, announced in a recent press release (http://cnw.fm/jGgV1) that it has submitted a Health Canada research application and has appointed a new member to its executive team. The research application has been submitted for the operation of a Kelowna-based research and development laboratory to work…